Boyd Fenton, MD
Gastroenterology · Lubbock, TXNPI 1174564694
Payments from drug & device makers
Across 350 payments — averaging $17.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Takeda Pharmaceuticals U.S.A., Inc.$824
- Boston Scientific$669
- Johnson & Johnson$610
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$551
- Daiichi Sankyo Inc.$468
- plus $1K from 29 others
What the payments were for
- Food & beverage$6,192100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 103 | $1,619 |
| Takeda Pharmaceuticals U.S.A., Inc. | 47 | $824 |
| Boston Scientific | 18 | $669 |
| Johnson & Johnson | 42 | $610 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 31 | $551 |
| Daiichi Sankyo Inc. | 23 | $468 |
| Intercept Pharmaceuticals, Inc. | 14 | $192 |
| Gilead | 9 | $143 |
| Pfizer | 8 | $110 |
| Intuitive Surgical | 1 | $97 |
| Sanofi | 4 | $77 |
| UCB, Inc. | 4 | $74 |
| QOL Medical, LLC | 2 | $60 |
| Redhill Biopharma Inc. | 3 | $55 |
| Ironwood Pharmaceuticals, Inc | 3 | $54 |
| Nestle Healthcare Nutrition Inc. | 4 | $54 |
| Pentax Of America, Inc. | 1 | $53 |
| AstraZeneca | 4 | $53 |
| Bristol Myers Squibb | 3 | $53 |
| Merck | 3 | $48 |
| Seagen Inc. | 2 | $39 |
| Pharmacosmos Therapeutics Inc. | 2 | $37 |
| Ferring Pharmaceuticals Inc. | 2 | $36 |
| Amgen | 3 | $36 |
| Astellas Pharma US Inc | 2 | $30 |
| Axonics, Inc. | 2 | $30 |
| Ardelyx, Inc. | 1 | $20 |
| Ipsen Biopharmaceuticals, Inc | 1 | $18 |
| Acacia Pharma Inc | 2 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| Ambu Inc. | 1 | $14 |
| Alnylam Pharmaceuticals Inc. | 1 | $12 |
| Eisai Inc. | 1 | $12 |
| Covidien LP | 1 | $12 |
| Gastrogpo, LLC | 1 | $0 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tremfya$123
- EXALT Model D$110
- EXALT$107
How this compares
$6,192 in reported general payments places this provider in the 60th percentile of 1,350 gastroenterology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Lubbock
- Houssam Al KharratLubbock$1.3M
- Eric LawitzSan Antonio$59.5M
- George DuvallTyler$17.5M
- John FordtranDallas$9.9M
- Timothy RitterSouthlake$7.7M
- Parvez MantryDallas$6.4M
- Mazen NoureddinHouston$6.1M
- Nadege GunnWaco$5.7M
- Michael BrownDallas$5.5M
- James MaherHouston$5.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.